Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography–mass spectrometry and application to pharmacokinetics

Quantitative determination of metformin, saxagliptin and 5-hydroxy saxagliptin simultaneously by hydrophilic interaction liquid chromatography - electrospray ionization mass spectrometry and its application to a bioequivalence study with a single-pill combination in human

(2018) Ying Peng et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Salting-out assisted liquid-liquid extraction coupled with hydrophilic interaction chromatography for the determination of biguanides in biological and environmental samples

(2018) Anas Alshishani et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Development and validation of a hydrophilic interaction liquid chromatography method for the quantitation of impurities in fixed-dose combination tablets containing rosuvastatin and metformin

(2018) George Machairas et al.   TALANTA

Ion-pair solid phase extraction for the simultaneous separation and quantitation of metformin and canagliflozin in human plasma by LC-MS/MS

(2018) Priyanka A. Shah et al.   MICROCHEMICAL JOURNAL

Simultaneous quantitation of metformin and dapagliflozin in human plasma by LC-MS/MS: Application to a pharmacokinetic study

(2018) Priyanka A. Shah et al.   BIOMEDICAL CHROMATOGRAPHY

LC–MS/MS Determination of Empagliflozin and Metformin

(2017) Bassam M. Ayoub et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

A validated UHPLC-QTOF-MS method for quantification of metformin and teneligliptin in rat plasma: Application to pharmacokinetic interaction study

(2017) David Paul et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Enhanced LC-MS/MS determination of alogliptin and metformin in plasma: Application to a pharmacokinetic study

(2017) Shereen Mowaka et al.   MICROCHEMICAL JOURNAL

Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations

(2017) Bassam M. Ayoub et al.   Scientific Reports

Initial Combination of Empagliflozin and Metformin in Patients With Type 2 Diabetes

(2016) Samy Hadjadj et al.   DIABETES CARE

LC–tandem mass spectrometry method for the simultaneous determination of metformin and sitagliptin in human plasma after ion-pair solid phase extraction

(2016) Priyanka A. Shah et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation

(2016) Bassam M. Ayoub   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Pharmacokinetics of Empagliflozin and Pioglitazone After Coadministration in Healthy Volunteers

(2015) Sreeraj Macha et al.   CLINICAL THERAPEUTICS

Pharmacokinetics and Pharmacodynamics of Twice Daily and Once Daily Regimens of Empagliflozin in Healthy Subjects

(2015) Sreeraj Macha et al.   CLINICAL THERAPEUTICS

Empagliflozin for the treatment of type 2 diabetes

(2014) Vidhya Jahagirdar et al.   EXPERT OPINION ON PHARMACOTHERAPY

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of Empagliflozin and Linagliptin After Coadministration in Healthy Male Volunteers

(2013) Christian Friedrich et al.   CLINICAL THERAPEUTICS

Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment

(2013) S. Macha et al.   DIABETES OBESITY & METABOLISM

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control

(2013) Helena Rodbard et al.   Endocrine Practice

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

Cellular and molecular mechanisms of metformin: an overview

(2011) Benoit Viollet et al.   CLINICAL SCIENCE

Add-on therapies to metformin for type 2 diabetes

(2010) Mansur Shomali   EXPERT OPINION ON PHARMACOTHERAPY

Global estimates of the prevalence of diabetes for 2010 and 2030

(2009) J.E. Shaw et al.   DIABETES RESEARCH AND CLINICAL PRACTICE